產(chǎn)品名稱 LY2228820 from BIOVISION, INC.
    產(chǎn)品貨號(hào) B1702-25
    產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià)，電話：010-67529703
    產(chǎn)品規(guī)格 25 mg
    產(chǎn)品品牌 BIOVISION, INC.
    產(chǎn)品概述
    產(chǎn)品詳情
    Edit&nbsp
    Product NameLY2228820
    DescriptionLY2228820 is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, but does not alter p38 MAPK activation. MW: 612.74. Purity >98%
    Size25 mg
    Concentrationn/a
    Applicationsn/a
    Other NamesLY2228820; LY 2228820; LY-2228820; LY2228820 dimesylate; Ralimetinib dimesylate; 5-(2-(tert-butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine dimethanesulfonate; 5-[2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)imidazo[4,5-b]pyridin-2-amine;methanesulfonic acid
    Gene, Accession, CAS #CAS: 862507-23-1
    Catalog #B1702-25
    Price
    Order / More InfoLY2228820 from BIOVISION, INC.
    Product Specific Referencesn/a
    產(chǎn)品資料 
    <strong id="itm00"><address id="itm00"></address></strong>
    <th id="itm00"></th>
    <acronym id="itm00"><label id="itm00"></label></acronym>

    3. 

    <th id="itm00"></th>